XML 100 R88.htm IDEA: XBRL DOCUMENT v3.21.1
SEGMENT INFORMATION - Segment Revenues and Profit (Details) - USD ($)
$ in Millions
3 Months Ended
May 26, 2020
Mar. 31, 2021
Mar. 31, 2020
Segment reporting information      
Revenues   $ 2,027 $ 2,012
Operating (loss) income   (221) 248
Amortization of intangible assets   (357) (436)
Goodwill impairments   (469) 0
Asset impairments   (148) (14)
Restructuring, integration and separation costs   (12) (4)
Other income (expense), net   30 (36)
Interest income   2 7
Interest expense   (368) (396)
Loss on extinguishment of debt $ (27) (5) (24)
Foreign exchange and other   1 (13)
Loss before (provision for) benefit from income taxes   (591) (178)
Bausch + Lomb      
Segment reporting information      
Revenues   881 875
Salix      
Segment reporting information      
Revenues   472 477
International Rx      
Segment reporting information      
Revenues   306 291
Ortho Dermatologics      
Segment reporting information      
Revenues   141 131
Diversified Products      
Segment reporting information      
Revenues   227 238
Operating Segment      
Segment reporting information      
Revenues   2,027 2,012
Operating (loss) income   916 894
Operating Segment | Bausch + Lomb      
Segment reporting information      
Revenues   881 875
Operating (loss) income   239 263
Operating Segment | Salix      
Segment reporting information      
Revenues   472 477
Operating (loss) income   327 319
Operating Segment | International Rx      
Segment reporting information      
Revenues   306 291
Operating (loss) income   109 98
Operating Segment | Ortho Dermatologics      
Segment reporting information      
Revenues   141 131
Operating (loss) income   70 47
Operating Segment | Diversified Products      
Segment reporting information      
Revenues   227 238
Operating (loss) income   171 167
Corporate      
Segment reporting information      
Operating (loss) income   $ (181) $ (156)